Ferring Pharmaceuticals Receives U.S. FDA Approval of Drug Substance Manufacturing Scale-up Process for Gene Therapy ADSTILADRIN® (nadofaragene firadenovec-vncg)

PARSIPPANY, N.J.–(BUSINESS WIRE)–Ferring Receives U.S. FDA Approval of Drug Substance Manufacturing Scale-up Process for ADSTILADRIN®

Recent Articles